1. Home
  2. LUNG vs USAS Comparison

LUNG vs USAS Comparison

Compare LUNG & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • USAS
  • Stock Information
  • Founded
  • LUNG 1995
  • USAS 1998
  • Country
  • LUNG United States
  • USAS Canada
  • Employees
  • LUNG N/A
  • USAS N/A
  • Industry
  • LUNG Industrial Specialties
  • USAS Metal Mining
  • Sector
  • LUNG Health Care
  • USAS Basic Materials
  • Exchange
  • LUNG Nasdaq
  • USAS Nasdaq
  • Market Cap
  • LUNG 124.0M
  • USAS 536.1M
  • IPO Year
  • LUNG 2020
  • USAS N/A
  • Fundamental
  • Price
  • LUNG $2.87
  • USAS $1.02
  • Analyst Decision
  • LUNG Buy
  • USAS Strong Buy
  • Analyst Count
  • LUNG 6
  • USAS 1
  • Target Price
  • LUNG $11.53
  • USAS $1.30
  • AVG Volume (30 Days)
  • LUNG 317.8K
  • USAS 2.0M
  • Earning Date
  • LUNG 07-30-2025
  • USAS 08-14-2025
  • Dividend Yield
  • LUNG N/A
  • USAS N/A
  • EPS Growth
  • LUNG N/A
  • USAS N/A
  • EPS
  • LUNG N/A
  • USAS N/A
  • Revenue
  • LUNG $87,473,000.00
  • USAS $102,883,000.00
  • Revenue This Year
  • LUNG $18.02
  • USAS $45.78
  • Revenue Next Year
  • LUNG $18.17
  • USAS $17.98
  • P/E Ratio
  • LUNG N/A
  • USAS N/A
  • Revenue Growth
  • LUNG 19.84
  • USAS 8.12
  • 52 Week Low
  • LUNG $2.50
  • USAS $0.21
  • 52 Week High
  • LUNG $9.37
  • USAS $1.05
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 39.07
  • USAS 76.51
  • Support Level
  • LUNG $2.62
  • USAS $0.80
  • Resistance Level
  • LUNG $2.88
  • USAS $0.90
  • Average True Range (ATR)
  • LUNG 0.17
  • USAS 0.06
  • MACD
  • LUNG 0.05
  • USAS 0.01
  • Stochastic Oscillator
  • LUNG 39.68
  • USAS 90.91

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

Share on Social Networks: